Medpace Holdings logo

Medpace HoldingsNASDAQ: MEDP

Profile

Sector:

Healthcare

Country:

United States

IPO:

11 August 2016

Next earnings report:

12 February 2025

Last dividends:

N/A

Next dividends:

N/A
$9.88 B
-30%vs. 3y high
93%vs. sector
-41%vs. 3y high
49%vs. sector
-51%vs. 3y high
93%vs. sector
-36%vs. 3y high
59%vs. sector

Price

after hours | 13 min ago
$317.96-$1.60(-0.50%)

Dividend

No data over the past 3 years
$533.32 M$534.88 M
$533.32 M$96.43 M

Analysts recommendations

Institutional Ownership

MEDP Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP
accesswire.com04 November 2024 Sentiment: -

NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation
accesswire.com03 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 3, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MEDP.

Medpace Holdings, Inc. May Have Defrauded The Public And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm
accesswire.com02 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP
prnewswire.com02 November 2024 Sentiment: NEGATIVE

NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws
globenewswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).

MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
accesswire.com01 November 2024 Sentiment: NEGATIVE

RADNOR, PA / ACCESSWIRE / November 1, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024.

MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
prnewswire.com30 October 2024 Sentiment: NEGATIVE

RADNOR, Pa. , Oct. 30, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Stockholders to Learn More About the Investigation
accesswire.com28 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MEDP.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm
accesswire.com27 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP
accesswire.com27 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

What type of business is Medpace Holdings?

Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.

What sector is Medpace Holdings in?

Medpace Holdings is in the Healthcare sector

What industry is Medpace Holdings in?

Medpace Holdings is in the Diagnostics & Research industry

What country is Medpace Holdings from?

Medpace Holdings is headquartered in United States

When did Medpace Holdings go public?

Medpace Holdings initial public offering (IPO) was on 11 August 2016

What is Medpace Holdings website?

https://www.medpace.com

Is Medpace Holdings in the S&P 500?

No, Medpace Holdings is not included in the S&P 500 index

Is Medpace Holdings in the NASDAQ 100?

No, Medpace Holdings is not included in the NASDAQ 100 index

Is Medpace Holdings in the Dow Jones?

No, Medpace Holdings is not included in the Dow Jones index

When was Medpace Holdings the previous earnings report?

No data

When does Medpace Holdings earnings report?

The next expected earnings date for Medpace Holdings is 12 February 2025